At the American Society of Hematology (ASH) meeting in Philadelphia on Monday, Michael Pfreundschuh ofSaarlandUniversity Medical School in Homburg, Germany presented similar data showing that closer dosing of chemotherapy was also helpful in non-Hodgkin's lymphoma.